In the lawsuit filed at the United States District Court for New Jersey, Mayne Pharma accused its rival of violating all 20 Orange Book-listed patents linked to IMVEXXY – a vaginal insert aimed at reducing pain during sexual intercourse after menopause. Orange Book-listed patents are those approved by the U.S. Food and Drug Administration (FDA) […]